Caroline Murphy

4.0k total citations
56 papers, 963 citations indexed

About

Caroline Murphy is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health. According to data from OpenAlex, Caroline Murphy has authored 56 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Psychiatry and Mental health. Recurrent topics in Caroline Murphy's work include Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (8 papers) and Retinal and Optic Conditions (6 papers). Caroline Murphy is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (8 papers) and Retinal and Optic Conditions (6 papers). Caroline Murphy collaborates with scholars based in United Kingdom, United States and Italy. Caroline Murphy's co-authors include Joanna Kelly, P. Nigel Leigh, Philip Hykin, Mary O’Brien, A Toby Prevost, Sobha Sivaprasad, Anita Burrell, Joana C. Vasconcelos, G.M. Kiebert and Paul McCrone and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Caroline Murphy

54 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline Murphy United Kingdom	19	207	179	170	144	136	56	963
Julia S. Benoit United States	14	98 0.5×	130 0.7×	141 0.8×	143 1.0×	60 0.4×	44	793
Jorge Mauriño Spain	22	186 0.9×	26 0.1×	224 1.3×	35 0.2×	202 1.5×	99	1.4k
Akshay Gopinathan Nair India	18	169 0.8×	301 1.7×	37 0.2×	92 0.6×	30 0.2×	86	1.1k
Krithika Rajagopalan United States	22	103 0.5×	223 1.2×	214 1.3×	152 1.1×	86 0.6×	99	1.8k
Dimitre G. Stefanov United States	16	107 0.5×	21 0.1×	158 0.9×	30 0.2×	112 0.8×	60	904
Abraham Kuruvilla India	16	169 0.8×	11 0.1×	202 1.2×	85 0.6×	105 0.8×	70	1.2k
Jana Pöttgen Germany	18	298 1.4×	34 0.2×	219 1.3×	64 0.4×	93 0.7×	45	1.1k
Laurie Wagner United States	15	313 1.5×	15 0.1×	63 0.4×	39 0.3×	71 0.5×	32	1.4k
Yanjun Chen United States	15	68 0.3×	186 1.0×	17 0.1×	117 0.8×	49 0.4×	55	1.2k
Ali Salimi Canada	19	109 0.5×	269 1.5×	145 0.9×	300 2.1×	86 0.6×	61	992

Countries citing papers authored by Caroline Murphy

Since Specialization

Citations

This map shows the geographic impact of Caroline Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Murphy more than expected).

Fields of papers citing papers by Caroline Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Murphy. The network helps show where Caroline Murphy may publish in the future.

Co-authorship network of co-authors of Caroline Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Murphy. A scholar is included among the top collaborators of Caroline Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Murphy. Caroline Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lochlainn, Mary Ní, Ruth C. E. Bowyer, Janne Marie Moll, et al.. (2024). Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial. Nature Communications. 15(1). 1859–1859. 42 indexed citations

Charteris, David G., Suzie Cro, Edward J. Casswell, et al.. (2023). A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma – the ASCOT study. Health Technology Assessment. 27(12). 1–50. 3 indexed citations

Cope, Andrew P., Joana C. Vasconcelos, Andrew Filer, et al.. (2023). OP0130 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL. Annals of the Rheumatic Diseases. 82. 86–86. 9 indexed citations

Chatters, Robin, Cindy Cooper, Alicia O’Cathain, et al.. (2022). Learning from COVID-19 related trial adaptations to inform efficient trial design—a sequential mixed methods study. BMC Medical Research Methodology. 22(1). 128–128. 5 indexed citations

Pennington, Becky, Abualbishr Alshreef, Laura Flight, et al.. (2021). Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study. PharmacoEconomics. 39(8). 913–927. 6 indexed citations

Hykin, Philip, A Toby Prevost, Sobha Sivaprasad, et al.. (2021). Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment. 25(38). 1–196. 12 indexed citations

Murphy, Caroline, Brian Keogh, & Louise Doyle. (2019). ‘There is no progression in prevention’ – The experiences of mental health nurses working with repeated self‐harm. International Journal of Mental Health Nursing. 28(5). 1145–1154. 10 indexed citations

Pennington, Mark, Howard Ring, Christopher Smith, et al.. (2019). The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study. Journal of Intellectual Disability Research. 63(12). 1391–1400. 7 indexed citations

Flight, Laura, Abualbishr Alshreef, P. Hykin, et al.. (2019). PIN156 INTRAVITREAL THERAPY WITH RANIBIZUMAB VS AFLIBERCEPT VS BEVACIZUMAB FOR MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION: A WITHIN TRIAL COST-UTILITY ANALYSIS. Value in Health. 22. S664–S664. 1 indexed citations

10.

Göebel, Andreas, Jatinder Bisla, Bernhard Frank, et al.. (2017). A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial). SHILAP Revista de lepidopterología. 4(5). 1–82. 15 indexed citations

11.

Marsden, John, Garry Stillwell, Jennifer Hellier, et al.. (2016). Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial. Contemporary Clinical Trials. 53. 36–43. 10 indexed citations

12.

Ring, Howard, Roxanne Hook, Christopher G. Smith, et al.. (2016). Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trial. Trials. 17(1). 297–297. 6 indexed citations

13.

Absoud, Michael, Jennifer Hellier, P A Brex, et al.. (2015). Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). BMJ Open. 5(5). e008312–e008312. 14 indexed citations

14.

Gow, Rachel V., Joanna Kelly, Caroline Murphy, et al.. (2015). Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial. Journal of Child and Adolescent Psychopharmacology. 25(10). 775–782. 27 indexed citations

15.

Sivaprasad, Sobha, A Toby Prevost, James Bainbridge, et al.. (2015). Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. BMJ Open. 5(9). e008405–e008405. 17 indexed citations

16.

Jones, Ashley, Naheed Jivraj, Rubika Balendra, et al.. (2014). Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(3-4). 285–291. 27 indexed citations

17.

Goldsmith, Kimberley, André Tylee, Ulrike Schmidt, et al.. (2013). One-day cognitive–behavioural therapy self-confidence workshops for people with depression: randomised controlled trial. The British Journal of Psychiatry. 204(3). 222–233. 46 indexed citations

18.

Kiebert, G.M., Caroline Murphy, John D. Mitchell, et al.. (2003). Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Quality of Life Research. 12(5). 565–574. 30 indexed citations

19.

Murphy, Caroline. (2001). Practice identity, collaboration, and optimal access to effective health care. Journal of Pediatric Health Care. 15(2). 98–100. 1 indexed citations

20.

Kiebert, G.M., Colin Green, Caroline Murphy, et al.. (2001). Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 191(1-2). 87–93. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact